Public list Eye Health (703)
:utilized "combinatorial chemistry" technology to discover lead therapeutic and diagnostic compounds.�MACUGEN, approved for wet age-related macular degeneration, was discovered using this technology. Upon NeXagen's merger with Ves...Show all
Company (Alive / Active)
Total Funding | Date of Last Funding | |
---|---|---|
NeXagen | $0M | Nov 10, 2019 |
See all 16 competitors |
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|---|---|---|
Thomas McNerney & Partners | Venture Capital | Stamford, Connecticut, United States | Other Investors |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Tweezer | Mar 23, 2016 | Apr 11, 2017 | Patent |
Portion of a make-up brush | Sep 06, 2016 | Apr 04, 2017 | Patent |
Portion of a make-up brush | May 28, 2015 | Oct 18, 2016 | Patent |